BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shou S, Liu M, Yang Y, Kang N, Song Y, Tan D, Liu N, Wang F, Liu J, Xie Y. Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates. Front Microbiol 2021;12:626553. [PMID: 34531831 DOI: 10.3389/fmicb.2021.626553] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 39.0] [Reference Citation Analysis]
Number Citing Articles
1 Di Y, Lew J, Goncin U, Radomska A, Rout SS, Gray BET, Machtaler S, Falzarano D, Lavender KJ. SARS-CoV-2 Variant-Specific Infectivity and Immune Profiles Are Detectable in a Humanized Lung Mouse Model. Viruses 2022;14:2272. [PMID: 36298826 DOI: 10.3390/v14102272] [Reference Citation Analysis]
2 Dogan AB, Dabkowski KE, Cadnum JL, Donskey CJ, von Recum HA. Polymer Additives to Personal Protective Equipment can Inactivate Pathogens. Ann Biomed Eng 2022. [PMID: 36243778 DOI: 10.1007/s10439-022-03100-1] [Reference Citation Analysis]
3 Jha A, Barker D, Lew J, Manoharan V, van Kessel J, Haupt R, Toth D, Frieman M, Falzarano D, Kodihalli S. Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection. Sci Rep 2022;12:16956. [PMID: 36216961 DOI: 10.1038/s41598-022-21223-2] [Reference Citation Analysis]
4 Clerbaux L, Mayasich SA, Muñoz A, Soares H, Petrillo M, Albertini MC, Lanthier N, Grenga L, Amorim M. Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19. JCM 2022;11:5691. [DOI: 10.3390/jcm11195691] [Reference Citation Analysis]
5 Abdelkader DH, Negm WA, Elekhnawy E, Eliwa D, Aldosari BN, Almurshedi AS. Zinc Oxide Nanoparticles as Potential Delivery Carrier: Green Synthesis by Aspergillus niger Endophytic Fungus, Characterization, and In Vitro/In Vivo Antibacterial Activity. Pharmaceuticals 2022;15:1057. [DOI: 10.3390/ph15091057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Seo S, Son JH, Lee J, Kim N, Yoo E, Kang A, Jang JY, On DI, Noh HA, Yun J, Park JW, Choi K, Lee H, Shin J, Seo J, Nam KT, Lee H, Seong JK, Choi Y. Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice. PLoS ONE 2022;17:e0272019. [DOI: 10.1371/journal.pone.0272019] [Reference Citation Analysis]
7 Niewold P, Ijsselsteijn ME, Verreck FAW, Ottenhoff THM, Joosten SA. An imaging mass cytometry immunophenotyping panel for non-human primate tissues. Front Immunol 2022;13:915157. [DOI: 10.3389/fimmu.2022.915157] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Konishi T. Mutations in SARS-CoV-2 are on the increase against the acquired immunity. PLoS One 2022;17:e0271305. [PMID: 35816505 DOI: 10.1371/journal.pone.0271305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hudák A, Morgan G, Bacovsky J, Patai R, Polgár TF, Letoha A, Pettko-Szandtner A, Vizler C, Szilák L, Letoha T. Biodistribution and Cellular Internalization of Inactivated SARS-CoV-2 in Wild-Type Mice. Int J Mol Sci 2022;23:7609. [PMID: 35886958 DOI: 10.3390/ijms23147609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tallmadge RL, Laverack M, Cronk B, Venugopalan R, Martins M, Zhang X, Elvinger F, Plocharczyk E, Diel DG. Viral RNA Load and Infectivity of SARS-CoV-2 in Paired Respiratory and Oral Specimens from Symptomatic, Asymptomatic, or Postsymptomatic Individuals. Microbiol Spectr 2022;10:e0226421. [PMID: 35575498 DOI: 10.1128/spectrum.02264-21] [Reference Citation Analysis]
11 Xue Y, Yang D, Vogel P, Stabenow J, Zalduondo L, Kong Y, Ravi Y, Sai-sudhakar CB, Parvathareddy J, Hayes E, Taylor S, Fitzpatrick E, Jonsson CB. Cardiopulmonary Injury in the Syrian Hamster Model of COVID-19. Viruses 2022;14:1403. [DOI: 10.3390/v14071403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Che YH, Kim YJ. Understanding the cellular pathogenesis of COVID-19 symptoms using organoid technology. Organoid 2022;2:e16. [DOI: 10.51335/organoid.2022.2.e16] [Reference Citation Analysis]
13 Zhao S, Fan J, Liu E. Animal Models for COVID-19 Therapeutic Development: Where We Are and Where We Need to Go. Front Microbiol 2022;13:907406. [DOI: 10.3389/fmicb.2022.907406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Acharjee A, Stephen Kingsly J, Kamat M, Kurlawala V, Chakraborty A, Vyas P, Vaishnav R, Srivastava S. Rise of the SARS-CoV-2 Variants: Can proteomics be the silver bullet? Expert Rev Proteomics 2022. [PMID: 35655386 DOI: 10.1080/14789450.2022.2085564] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bienzle D, Rousseau J, Marom D, Macnicol J, Jacobson L, Sparling S, Prystajecky N, Fraser E, Weese JS. Risk Factors for SARS-CoV-2 Infection and Illness in Cats and Dogs1. Emerg Infect Dis 2022;28. [DOI: 10.3201/eid2806.220423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Kurup D, Wirblich C, Zabihi Diba L, Lambert R, Watson M, Shaikh N, Ramage H, Solomides C, Schnell MJ. A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model. Viruses 2022;14:1126. [DOI: 10.3390/v14061126] [Reference Citation Analysis]
17 Dunai C, Collie C, Michael BD. Immune-Mediated Mechanisms of COVID-19 Neuropathology. Front Neurol 2022;13:882905. [DOI: 10.3389/fneur.2022.882905] [Reference Citation Analysis]
18 Merkuleva IA, Shcherbakov DN, Borgoyakova MB, Isaeva AA, Nesmeyanova VS, Volkova NV, Aripov VS, Shanshin DV, Karpenko LI, Belenkaya SV, Kazachinskaia EI, Volosnikova EA, Esina TI, Sergeev AA, Titova KA, Konyakhina YV, Zaykovskaya AV, Pyankov OV, Kolosova EA, Viktorina OE, Shelemba AA, Rudometov AP, Ilyichev AA. Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines? Viruses 2022;14:1060. [PMID: 35632800 DOI: 10.3390/v14051060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Kumar A, Grams TR, Bloom DC, Toth Z. Signaling Pathway Reporter Screen with SARS-CoV-2 Proteins Identifies nsp5 as a Repressor of p53 Activity. Viruses 2022;14:1039. [DOI: 10.3390/v14051039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Schreiner T, Allnoch L, Beythien G, Marek K, Becker K, Schaudien D, Stanelle-Bertram S, Schaumburg B, Mounogou Kouassi N, Beck S, Zickler M, Gabriel G, Baumgärtner W, Armando F, Ciurkiewicz M. SARS-CoV-2 Infection Dysregulates Cilia and Basal Cell Homeostasis in the Respiratory Epithelium of Hamsters. Int J Mol Sci 2022;23:5124. [PMID: 35563514 DOI: 10.3390/ijms23095124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
21 Nickl P, Raishbrook MJ, Syding LA, Sedlacek R. Advances in Modelling COVID-19 in Animals. Front Drug Discov 2022;2. [DOI: 10.3389/fddsv.2022.899587] [Reference Citation Analysis]
22 Käufer C, Schreiber CS, Hartke AS, Denden I, Stanelle-Bertram S, Beck S, Kouassi NM, Beythien G, Becker K, Schreiner T, Schaumburg B, Beineke A, Baumgärtner W, Gabriel G, Richter F. Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. EBioMedicine 2022;79:103999. [PMID: 35439679 DOI: 10.1016/j.ebiom.2022.103999] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
23 Liu X, Mostafavi H, Ng WH, Freitas JR, King NJC, Zaid A, Taylor A, Mahalingam S. The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan. mBio 2022;:e0068322. [PMID: 35420469 DOI: 10.1128/mbio.00683-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Thakur N, Gallo G, Newman J, Peacock TP, Biasetti L, Hall CN, Wright E, Barclay W, Bailey D. SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host ranges. J Gen Virol 2022;103. [PMID: 35377298 DOI: 10.1099/jgv.0.001735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
25 Kleeman EA, Gubert C, Hannan AJ. Transgenerational epigenetic impacts of parental infection on offspring health and disease susceptibility. Trends in Genetics 2022. [DOI: 10.1016/j.tig.2022.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Gunasekara S, Tamil Selvan M, Miller CA, Rudd JM. Thinking Outside the Box: Utilizing Nontraditional Animal Models for COVID-19 Research. IJTM 2022;2:113-33. [DOI: 10.3390/ijtm2010010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Giacca M, Shah AM. The pathological maelstrom of COVID-19 and cardiovascular disease. Nat Cardiovasc Res 2022;1:200-210. [DOI: 10.1038/s44161-022-00029-5] [Reference Citation Analysis]
28 Kurup D, Wirblich C, Diba LZ, Lambert R, Watson M, Shaikh N, Ramage H, Solomides C, Schnell MJ. A single-dose of the deactivated rabies virus vectored COVID-19 vaccine, CORAVAX, is highly efficacious and alleviates lung inflammation in the hamster model.. [DOI: 10.1101/2022.02.21.481324] [Reference Citation Analysis]
29 Radhakrishnan RK, Kandasamy M. SARS-CoV-2-Mediated Neuropathogenesis, Deterioration of Hippocampal Neurogenesis and Dementia. Am J Alzheimers Dis Other Demen 2022;37:15333175221078418. [PMID: 35133907 DOI: 10.1177/15333175221078418] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
30 Piret J, Boivin G. Viral Interference between Respiratory Viruses. Emerg Infect Dis 2022;28:273-81. [DOI: 10.3201/eid2802.211727] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 24.0] [Reference Citation Analysis]
31 Konishi T. Increasing SARS-CoV-2 mutations against vaccination-acquired immunity.. [DOI: 10.1101/2022.01.30.22270133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Ebenig A, Muraleedharan S, Kazmierski J, Todt D, Auste A, Anzaghe M, Gömer A, Postmus D, Gogesch P, Niles M, Plesker R, Miskey C, Serra MG, Breithaupt A, Hörner C, Kruip C, Ehmann R, Ivics Z, Waibler Z, Pfaender S, Wyler E, Landthaler M, Kupke A, Nouailles G, Goffinet C, Brown RJ, Mühlebach MD. In contrast to TH2-biased approaches, TH1 COVID-19 vaccines protect Syrian hamsters from severe disease in the absence of dexamethasone-treatable vaccine-associated enhanced respiratory pathology.. [DOI: 10.1101/2021.12.28.474359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 O’connor MA, Erasmus JH, Randall S, Archer J, Lewis TB, Brown B, Fredericks M, Groenier S, Iwayama N, Ahrens C, Garrison W, Wangari S, Guerriero KA, Fuller DH. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques. Front Immunol 2021;12. [DOI: 10.3389/fimmu.2021.800723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Yan K, Dumenil T, Tang B, Le TT, Bishop C, Suhrbier A, Rawle DJ. ACE2-independent SARS-CoV-2 infection and mouse adaption emerge after passage in cells expressing human and mouse ACE2.. [DOI: 10.1101/2021.12.16.473063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Wyler E, Adler JM, Eschke K, Alves GT, Peidli S, Pott F, Kazmierski J, Michalick L, Kershaw O, Bushe J, Andreotti S, Pennitz P, Abdelgawad A, Postmus D, Goffinet C, Kreye J, Reincke SM, Prüss H, Blüthgen N, Gruber AD, Kuebler WM, Witzenrath M, Landthaler M, Nouailles G, Trimpert J. Insights into standards of care – dexamethasone and antibodies against COVID-19 in hamster models.. [DOI: 10.1101/2021.12.17.473180] [Reference Citation Analysis]
36 Thakur N, Gallo G, Newman J, Peacock TP, Biasetti L, Hall CN, Wright E, Barclay W, Bailey D. SARS-CoV-2 variants of concern Alpha, Beta, Gamma and Delta have extended ACE2 receptor host-ranges.. [DOI: 10.1101/2021.11.23.469663] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Gligorijevic N, Radomirovic M, Nedic O, Stojadinovic M, Khulal U, Stanic-Vucinic D, Cirkovic Velickovic T. Molecular Mechanisms of Possible Action of Phenolic Compounds in COVID-19 Protection and Prevention. Int J Mol Sci 2021;22:12385. [PMID: 34830267 DOI: 10.3390/ijms222212385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Tallmadge RL, Laverack M, Cronk B, Venugopalan R, Martins M, Zhang X, Elvinger F, Plocharczyk E, Diel DG. Viral load and infectivity of SARS-CoV-2 in paired respiratory and oral specimens from symptomatic, asymptomatic or post-symptomatic individuals.. [DOI: 10.1101/2021.11.13.21266305] [Reference Citation Analysis]